Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial

Cancer
Rudolf WeissDieter Huhn

Abstract

Highly active antiretroviral therapy (HAART) has improved the survival of patients with acquired immunodeficiency syndrome-related lymphoma (ARL). The German ARL Study Group investigated whether HAART administered concomitantly with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy compromised the course of immune parameters during and after chemotherapy and exerted a positive effect on remission and survival. From 1997 to 2001, 72 patients with ARL were stratified prospectively into a standard-risk group (n = 48 patients) and a high-risk group (n = 24 patients) with either 0-1 or 2-3 of the following risk factors: CD4 < 50/microL, prior opportunistic infection, and/or a World Health Organization performance status > or = 3. Patients in the high-risk group received > or =75% of the CHOP regimen. In the standard-risk group (CD4 = 223/muL; age-adjusted International Prognostic Index [aaIPI], 38% > or = 2), the complete remission (CR) rate was 79%, and median survival was not reached after a median 47 months of follow-up. CD4 counts did not change from baseline to 4 weeks after the end of chemotherapy (206/microL). In the high-risk group (CD4 = 34/muL; aaIPI, 88% > or = 2), the CR rate was 29%, and the...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Oct 3, 1999·International Journal of Cancer. Journal International Du Cancer·S FranceschiC La Vecchia
Nov 18, 2000·Journal of the National Cancer Institute·UNKNOWN International Collaboration on HIV and Cancer
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L RatnerUNKNOWN AIDS Malignancy Consortium
Jun 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C S Rabkin
Jun 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U Tirelli, D Bernardi
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Henry K TamRoger Detels
Jan 15, 2003·Annual Review of Medicine·David T Scadden
Jul 25, 2003·Expert Opinion on Pharmacotherapy·Ingo G H Schmidt-WolfDieter Huhn
Sep 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cecilia SimonelliUmberto Tirelli
Nov 25, 2003·Hematology·Paul A VolberdingAlexandra M Levine
Apr 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph A SparanoJamie H Von Roenn
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Justin StebbingMark Bower

❮ Previous
Next ❯

Citations

Apr 26, 2011·Medical Oncology·Tanja MestiBarbara Jezeršek Novaković
Dec 14, 2011·AIDS Research and Human Retroviruses·Mark ManakMarco Schito
Dec 7, 2010·The Journal of Antimicrobial Chemotherapy·Paul A Pham, Charles Flexner
Sep 1, 2007·Current Opinion in Oncology·Joseph A Sparano
Feb 28, 2008·Current Opinion in Oncology·Nina D Wagner-Johnston, Richard F Ambinder
Jun 23, 2009·Malawi Medical Journal : the Journal of Medical Association of Malawi·Emma CrutchlowTom Latham
Nov 5, 2014·Intractable & Rare Diseases Research·Seiji OkadaMihoko Yotsumoto
May 28, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Brian Thabile FlepisiBernd Rosenkranz
Mar 9, 2012·Advances in Hematology·Prakash Vishnu, David M Aboulafia
Feb 28, 2007·Leukemia & Lymphoma·Guillermo J Ruiz-ArgüellesJavier Garcés-Eisele
Jul 11, 2013·Leukemia & Lymphoma·Ulas Darda BayraktarJuan Carlos Ramos
May 1, 2009·Expert Review of Clinical Pharmacology·Antonello MalfitanoGiorgio Barbarini
Apr 9, 2013·Expert Opinion on Biological Therapy·Morag Meriel Griffin, Nick Morley
Aug 24, 2010·Expert Opinion on Pharmacotherapy·Michele SpinaAntonino Carbone
Apr 23, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Alain MakinsonVincent Le Moing
Mar 3, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Alain MakinsonJacques Reynes
Mar 14, 2012·Best Practice & Research. Clinical Haematology·Lawrence D Kaplan
Aug 5, 2010·Archives of Biochemistry and Biophysics·Benjamin StoneEugene McCloskey
Mar 9, 2010·Best Practice & Research. Clinical Gastroenterology·Walter Heise
Jan 13, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Armelle LavoléJacques Cadranel
Nov 21, 2007·Gender Medicine·Jayson WangMark Bower
Aug 27, 2010·Journal of Surgical Oncology·Mary ReedEugene Albu
Dec 15, 2015·Expert Review of Hematology·Chia-Ching J Wang, Lawrence D Kaplan
Aug 27, 2014·Journal of Medical Virology·Andrew M MusyokiM Jeffrey Mphahlele
Dec 27, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Thomas R SpitzerDavid T Scadden
Jan 29, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Amrita Krishnan
Feb 10, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ramya RamaswamiMark Bower
Oct 19, 2016·Current Opinion in HIV and AIDS·Gita Suneja, Anna Coghill
Nov 10, 2007·British Journal of Haematology·Antonino Carbone, Annunziata Gloghini
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Arturo J Martí-CarvajalAble Lawrence
Jul 2, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gita SunejaEric A Engels
Nov 16, 2019·Blood Research·A H RudreshaMulchandani Nikita
Aug 18, 2020·Current Oncology Reports·Kai Hübel
Jul 12, 2021·Bulletin du cancer·Illias Tazi, Fatima Zahra Lahlimi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.